Randomized clinical trials for psoriasis 1977-2000: The EDEN survey

Journal of Investigative Dermatology

Volumn 120, Issue 5, 2003, Pages 738-741

  Naldi, Luigi ^a,b,j   Svensson, Ake ^c   Diepgen, Thomas ^d   Elsner, Peter ^e   Grob, Jean Jacques ^f   Coenraads, Pieter Jan ^g   Bavinck, Jan Nico Bouwes ^h   Williams, Hywel ⁱ  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b Bergamo General Hospital   (Italy)

^c LUND UNIVERSITY   (Sweden)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^f AIX MARSEILLE UNIVERSITY   (France)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^j OSPEDALI RIUNITI   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; ETRETINATE; KERATOLYTIC AGENT; PLACEBO; PSORALEN; STEROID; VITAMIN D DERIVATIVE;

ADULT; AGED; CELL PROLIFERATION; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; INFLAMMATORY CELL; KERATINOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; PUVA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SELF CONTROL; ULTRAVIOLET B RADIATION;

EID: 0038636510     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12145.x     Document Type: Review

References (29)

1. Al-Suwaidan SN, Feldman SR: Clearance is not a realistic expectation of psoriasis treatment. J Am Acad Dermatol 42:796-802, 2000
2. Ashcroft DM, Wan Po AL, Williams HC, Griffiths CE: Clinical measures of disease severity and outcome in psoriasis: A critical appraisal of their quality. Br J Dermatol 141:185-191, 1999
3. Ashcroft DM, Wan Po AL, Williams HC, Griffiths CE: Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis. BMJ 320:963-967, 2000
4. Bailar JCIII, Louis TA, Lavori PW, Polansky M: Studies without internal controls. N Engl J Med 311:156-162, 1984
5. Barker JNWN: The pathophysiology of psoriasis. Lancet 338:227-230, 1991
6. Bigby M, Stern RS, Bigby J: An evaluation of method reporting and use in clinical trials in dermatology. Arch Dermatol 121:1394-1399, 1985
7. Chalmers TC, Smith H, Blackburn B, et al: A method for assessing the quality of a randomized control trial. Controlled Clin Trials 2:31-49, 1981
8. DerSimonian R, Charette LJ, McPeek B, Mosteller F: Reporting on methods in clinical trials. N Engl J Med 306:1332-1337, 1982
9. Ellis CN, Krueger GG: Alefacept Clinical Study Group. Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. N Engl J Med 345:284-287, 2001
10. Griffiths CE, Clark CM, Chalmers RJ, Po AL, Williams HC: A systematic review of treatments for severe psoriasis. Health Technol Assess 4:1-125, 2000
11. Italian Multicenter Study Group on Cyclosporin in Psoriasis: Cyclosporin versus etretinate: Italian multicenter trial in severe plaque-form psoriasis. Dermatology 187 (Suppl):8-18, 1993
12. Juni P, Altman DG, Egger M: Assessing the quality of controlled clinical trials. In: Egger M, Davey Smith G, Altman DG (eds). Systematic Reviews in Health Care: Meta-Analyis in Context, 2nd edn. London: BMJ Books, 2001
13. Kirby B, Richards HL, Woo O, Hindle E, Main CJ, Griffiths CE: Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol 45:72-76, 2001
14. Krueger G, Koo J, Lebwohl M, Menter A, Stern KS, Rolstad T: The impact of psoriasis on quality of life: Results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 137:352-353, 2001
15. Lavori PW, Louis TA, Bailar J C, Polansky M: Designs for experiments. Parallel comparisons of treatment. N Engl J Med 309:1291-1298, 1983
16. Louis TA, Lavori PW, Bailar JCIII, Polansky M: Crossover and self-controlled designs in clinical research. N Engl J Med 310:24-31, 1984
17. Mahrle G, Schulze H-J, Farber L, Weidinger G, Steigleder GK: Low-dose short-term cyclosporine versus etretinate in psoriasis: Improvement of skin, nail, and joint involvement. J Am Acad Dermatol 32:78-88, 1995
18. Marks R, Barton SP, Shuttleworth D, Finlay AY: Assessment of disease progress in psoriasis. Arch Dermatol 125:235-240, 1989
19. Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ: Etanercept in the treatment of psoriatic arthritis and psoriasis: A randomised clinical trial. Lancet 356:385-390, 2000
20. Moher D, Pham B, Klassen TP, et al: What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol. 53:964-972, 2000
21. Perrott SB, Muray AH, Lowe J, Mathieson CM: The psychosocial impact of psoriasis: Physical severity, quality of life, and stigmatization. Physiol Behav 70:567-571, 2000
22. Petersen LJ, Kristensen JK: Selection of patients for psoriasis clinical trials: A survey of the recent dermatological literature. J Dermatol Treat 3:171-176, 1992
23. Schiffner R, Schiffner-Rohe J, Gerstenhauer M, Hofstadter F, Landthaler M, Stolz W: Differences in efficacy between intention-to-treat and per-protocol analyses for patients with psoriasis vulgaris and atopic dermatitis: Clinical and pharmacoeconomic implications. Br J Dermatol 144:1154-1160, 2001
24. Stern RS: Psoriasis. Lancet 350:349-353, 1997
25. Stern RS, Beer JZ, Mills DK: Lack of consensus among experts on the choice of UV therapy for psoriasis. Arch Dermatol 135:1187-1192, 1999
26. Van de Kerkhof PC, de Hoop D, de Korte J, Cobelens SA, Kuipers MV: Patient compliance and disease management in the treatment of psoriasis in the Netherlands. Dermatology 200:292-298, 2000
27. Williams HC, Seed P: Inadequate size of "negative" clinical trials in dermatology. Br J Dermatol 128:317-326, 1993
28. Wright JG: Evaluating the outcome of treatment: Shouldn't we be asking patients if they are better? J Clin Epidemiol 53:549-553, 2000
29. Zachariae H, Zachariae R, Blomqvist K, Davidsson S, Molin L, Mork C, Sigurgeirsson B: Treatment of psoriasis in the Nordic countries: A questionnaire survey from 5739 members of the psoriasis associations data from the Nordic Quality of Life Study. Acta Derm Venereol 81:116-121, 2001